Dong Moon Shin, MD, FACP, FAAAS

One star
One star
One star
One star
One half star

Rating: 4.7 out of 5 (91 ratings)

Role

Medical Oncology
Specialty

Head and Neck Cancer Thyroid Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1988

Call 404-778-1900

Background

Dong Moon Shin, MD, FACP, is the Frances Kelly Blomeyer Distinguished Endowed Chair in Cancer Research, Professor of Hematology and Medical Oncology, Professor of Otolaryngology, Professor of Biomedical Engineering, Director of the Head and Neck Cancer SPORE Program and Georgia Cancer Coalition Distinguished Scholar at Winship Cancer Institute of Emory University.

A board certified medical oncologist by the American Board of Internal Medicine, Dr. Shin is sought after for the treatment of head and neck cancer along with mesothelioma, thymoma and thymic carcinoma. Currently he is focusing on treatment and research in head and neck cancer.

Dr. Shin has a highly successful scholar and research track record as a head and neck cancer investigator. He is a well-established, internationally and nationally recognized clinician and investigator in head and neck cancer research related to biology, biomarkers, chemoprevention, biochemoprevention, new drug discovery by nanotherapeutics, and new molecularly-based and immune-based innovative therapies. He has published more than 350 articles in the professional journals in addition to numerous books and book chapters related to head and neck cancer and other cancers.

Dr. Shin is a Fellow of the American College of Physicians and a Fellow of the American Association for the Advancement of Science, and has been consecutively recognized as one of America's Top Doctors in Oncology in Castle Connolly Medial Ltd., and Top Doctors in Atlanta Magazinesince since 2005.

He has been also yearly recognized as the Best Doctors in America since 2003.

Prior to joining Emory, he served as a faculty member in the Department of Head and Neck/Thoracic Medical Oncology at M.D. Anderson Cancer Center, in Houston, and also served as Professor of Oncology and Director of Head and Neck Cancer Program at the University of Pittsburgh.

Dr. Shin graduated from Medical School in Yonsei University College of Medicine in Seoul, Korea in 1975. He completed Internships at Yonsei University Hospital in 1979 and at Cook County Hospital in Chicago in 1983. He also completed his Residency in Internal Medicine at Cook County Hospital in 1985 and his Fellowship in Medical Oncology at University of Texas, M.D. Anderson Cancer Center in Houston in 1988.

Titles & Roles

Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine
Adjunct Professor, Department of Otolaryngology

Emory University School of Medicine
Adjunct Professor of Biomedical Engineering

The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University

Education & Training

Education

Fellowship, Medical Oncology, 1988
Univ of TX M.D. Anderson Cancer Ctr
Residency, Internal Medicine, 1985
Cook County Hospital
Internship, Internal Medicine, 1983
Cook County Hospital
Medical Education, MD, 1975
Yonsei University

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1989
Internal Medicine
American Board of Internal Medicine, 1985

Professional Memberships

American Association of Cancer Research
American College of Physicians (Fellow)
American Head and Neck Society
American Society of Clinical Oncology
American Association of the Advancement of Science (Fellow)

Research

View Current Clinical Trials


A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma Phase III Conditions Neoplasms, Head and Neck Location Emory University Hospital Midtown
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer Phase IV Conditions Nasopharyngeal Cancer Recurrent Location Emory University Hospital Midtown
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer Phase I Conditions Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Metastatic Sinonasal Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Sinonasal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Unknown Primary, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8 Location Emory University Hospital Midtown

Grants

View Grants

Grant Number	Title
1R01CA262123-01A1	Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck
3R01CA262123-02S1	Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck
5K12CA237806-05	Emory Clinical Oncology Career Development Award K12 Program
5R01CA262123-02	Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck

Publications

Title/Journal	Authors	Publication Date
Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	NC Schmitt, WA Stokes, JE Bates, BLC Kinney, J Remick, MW McDonald, S Rudra, M Steininger, M Oyewole, MR Patel, AS Kaka, JH Gross, J Switchenko, CE Steuer, DM Shin, NF Saba	05/12/2025
Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up. Head & neck	P Kim, NF Saba, A McCook-Veal, Y Liu, AM Klein, JJ Beitler, A Chen, FR Khuri, DM Shin	04/28/2025
Neoadjuvant chemotherapy and surgery versus surgery for organ preservation of T3 and T4a nasal and paranasal sinus squamous cell carcinoma (NPNSCC) ECOG-ACRIN EA3163. Clinical cancer research : an official journal of the American Association for Cancer Research	NF Saba, Y Flamand, DT Lin, CH Chung, MW McDonald, S Flampouri, SA Khan, CH Snyderman, EY Hanna, IH El-Sayed, CA Solares, CH Le, M Ghaly, PH Hwang, DM Shin, RS Axelrod, CV Ikpeazu, DR Adkins, F Duan, M Cohen, MA Samuels, PL Swiecicki, RM Subramaniam, AB Chakravarthy, BA Burtness	04/14/2025
Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer. Cancer medicine	TJ Kristoff, S Evans, P Nayi, M Abousaud, S Goyal, Y Liu, D Shin, CE Steuer, NF Saba, NC Schmitt	03/01/2025
DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism. Molecular psychiatry	C Xiao, G Peng, KN Conneely, H Zhao, JC Felger, EC Wommack, KA Higgins, DM Shin, NF Saba, DW Bruner, AH Miller	01/01/2025
Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research	NF Saba, R Chaudhary, K Kirtane, A Marra, A Ekpenyong, A McCook-Veal, NC Schmitt, JH Gross, MR Patel, J Remick, JE Bates, MW McDonald, SF Rudra, WA Stokes, M Biernacki, X Song, RJC Slebos, Y Liu, CE Steuer, DM Shin, Y Teng, CH Chung	10/15/2024
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression. Cells	H Sabit, B Arneth, S Abdel-Ghany, EF Madyan, AH Ghaleb, P Selvaraj, DM Shin, R Bommireddy, A Elhashash	10/09/2024
Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives. Cancer prevention research (Philadelphia, Pa.)	S Han, R Bommireddy, P Kim, P Selvaraj, DM Shin	10/01/2024
Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage. Head & neck	S Pamulapati, M Abousaud, Y Li, A Ekpenyong, S Rudra, JS Remick, JE Bates, WA Stokes, MW McDonald, NC Schmitt, MW El-Deiry, MR Patel, CE Steuer, JM Switchenko, DM Shin, Y Teng, A Hammond, NF Saba	09/01/2024
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial. JAMA oncology	NF Saba, SJ Wong, T Nasti, AA McCook-Veal, MW McDonald, WA Stokes, AM Anderson, A Ekpenyong, M Rupji, M Abousaud, S Rudra, JE Bates, JS Remick, NP Joshi, NM Woody, M Awan, JL Geiger, A Shreenivas, J Samsa, MC Ward, NC Schmitt, MR Patel, KA Higgins, Y Teng, CE Steuer, DM Shin, Y Liu, R Ahmed, SA Koyfman	07/01/2024
Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement. The Laryngoscope	RJ So, JC Hidalgo Lopez, SA Ballestas, AM Klein, C Steuer, DM Shin, M Abousaud, Y Teng, NF Saba, AT Tkaczuk, ES Schaefer, TY Seiwert, K McClellan, SR Best	02/01/2024
Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study. Journal of psychosomatic research	Y Lin, G Peng, DW Bruner, AH Miller, NF Saba, KA Higgins, DM Shin, H Claussen, HR Johnston, MC Houser, EC Wommack, C Xiao	12/01/2023
Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study. Brain, behavior, and immunity	C Xiao, V Fedirko, H Claussen, H Richard Johnston, G Peng, S Paul, KM Maner-Smith, KA Higgins, DM Shin, NF Saba, EC Wommack, DW Bruner, AH Miller	10/01/2023
Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis. The Laryngoscope	SA Ballestas, J Hidalgo Lopez, AM Klein, C Steuer, DM Shin, M Abousaud, NC Schmitt, Y Teng, NF Saba, AT Tkaczuk	10/01/2023
Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study. Brain, behavior, & immunity - health	Z Amirkhanzadeh Barandouzi, DW Bruner, AH Miller, S Paul, JC Felger, EC Wommack, KA Higgins, DM Shin, NF Saba, C Xiao	07/01/2023
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood. International journal of radiation oncology, biology, physics	DC Qian, BC Ulrich, G Peng, H Zhao, KN Conneely, AH Miller, DW Bruner, RC Eldridge, EC Wommack, KA Higgins, DM Shin, NF Saba, AK Smith, B Burtness, HS Park, WA Stokes, JJ Beitler, C Xiao	04/01/2023
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial. Nature medicine	NF Saba, CE Steuer, A Ekpenyong, A McCook-Veal, K Magliocca, M Patel, NC Schmitt, W Stokes, JE Bates, S Rudra, J Remick, M McDonald, M Abousaud, AC Tan, MZH Fadlullah, R Chaudhary, J Muzaffar, K Kirtane, Y Liu, GZ Chen, DM Shin, Y Teng, CH Chung	04/01/2023
A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy. Cancer	Y Lin, DW Bruner, S Paul, AH Miller, NF Saba, KA Higgins, DM Shin, W Zhang, C Miaskowski, C Xiao	10/01/2022
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	CH Chung, J Li, CE Steuer, P Bhateja, M Johnson, J Masannat, MI Poole, F Song, JC Hernandez-Prera, H Molina, BM Wenig, S Kumar, C Kuperwasser, PJ Stephens, JM Farinhas, DM Shin, JA Kish, J Muzaffar, K Kirtane, JW Rocco, MJ Schell, NF Saba, M Bonomi	06/01/2022
Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults. Tumour virus research	J Riddell, AF Brouwer, HM Walline, LP Campredon, R Meza, MC Eisenberg, EC Andrus, RL Delinger, ML Yost, JK McCloskey, TB Thomas, S Huang, RL Ferris, DM Shin, C Fakhry, T Ow, D Li, A Berlot, TE Carey, NF Schlecht	06/01/2022
A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer. Cancers	JE Bauman, Z Chen, C Zhang, JP Ohr, RL Ferris, GM McGorisk, S Brandt, S Srivatsa, AY Chen, CE Steuer, DM Shin, NF Saba, FR Khuri, TK Owonikoko	05/26/2022
Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas. The oncologist	P Vijayvargiya, S Trivedi, M Rupji, H Song, Y Liu, R Jiang, AS Kaka, GZ Chen, W Stokes, C Steuer, DM Shin, JJ Beitler, MR Patel, A Aiken, NF Saba	02/03/2022
The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures. Head & neck	VR Dhere, CE Escott, S Tian, JM Switchenko, JP Bell, WA Stokes, MW McDonald, KR Magliocca, BJ Boyce, AS Kaka, CE Steuer, NF Saba, DM Shin, C Xiao, MR Patel, JJ Beitler	02/01/2022
Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma. Journal of the American Society of Cytopathology	OB Ogunbona, X Lin, JL Hornick, DJ Lubin, Q Wang, MD Reid, F Schneider, D Li, DM Shin, Q Shi	01/01/2022
Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC). Oral oncology	L Shu, D Wang, S Nannapaneni, Y Sun, CC Griffith, X Wang, Z Chen, M Patel, M El-Deiry, DM Shin, ZG Chen, NF Saba	11/01/2021
Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology	RC Eldridge, K Uppal, DN Hayes, MR Smith, X Hu, ZS Qin, JJ Beitler, AH Miller, EC Wommack, KA Higgins, DM Shin, B Ulrich, DC Qian, NF Saba, DW Bruner, DP Jones, C Xiao	10/01/2021
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study. Cancer	C Xiao, JJ Beitler, G Peng, ME Levine, KN Conneely, H Zhao, JC Felger, EC Wommack, CE Chico, S Jeon, KA Higgins, DM Shin, NF Saba, BA Burtness, DW Bruner, AH Miller	09/15/2021
Incidence trends of squamous cell carcinoma of the head and neck (SCCHN) in the aging population--A SEER-based analysis from 2000 to 2016. Cancer medicine	MA Taylor, J Switchenko, W Stokes, MR Patel, M McDonald, C Steuer, A Aiken, JJ Beitler, DM Shin, NF Saba	09/01/2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer. International journal of radiation oncology, biology, physics	C Xiao, AH Miller, G Peng, ME Levine, KN Conneely, H Zhao, RC Eldridge, EC Wommack, S Jeon, KA Higgins, DM Shin, NF Saba, AK Smith, B Burtness, HS Park, ML Irwin, LM Ferrucci, B Ulrich, DC Qian, JJ Beitler, DW Bruner	09/01/2021
Functional HPV-specific PD-1⁺ stem-like CD8 T cells in head and neck cancer. Nature	CS Eberhardt, HT Kissick, MR Patel, MA Cardenas, N Prokhnevska, RC Obeng, TH Nasti, CC Griffith, SJ Im, X Wang, DM Shin, M Carrington, ZG Chen, J Sidney, A Sette, NF Saba, A Wieland, R Ahmed	09/01/2021
Cisplatin-mediated activation of glucocorticoid receptor induces platinum resistance via MAST1. Nature communications	C Pan, J Kang, JS Hwang, J Li, AC Boese, X Wang, L Yang, TJ Boggon, GZ Chen, NF Saba, DM Shin, KR Magliocca, L Jin, S Kang	08/16/2021
The role of the gut microbiome in cancer-related fatigue: pilot study on epigenetic mechanisms. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	C Xiao, V Fedirko, J Beitler, J Bai, G Peng, C Zhou, J Gu, H Zhao, IH Lin, CE Chico, S Jeon, TM Knobf, KN Conneely, K Higgins, DM Shin, N Saba, A Miller, D Bruner	06/01/2021
Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models. Oncology reports	ARMR Amin, D Wang, S Nannapaneni, R Lamichhane, ZG Chen, DM Shin	05/01/2021
Socioeconomic Factors Influence the Impact of Tumor HPV Status on Outcome of Patients With Oropharyngeal Squamous Cell Carcinoma. JCO oncology practice	JA Marks, JM Switchenko, CE Steuer, M Ryan, MR Patel, MW McDonald, K Higgins, JJ Beitler, DM Shin, TW Gillespie, NF Saba	03/01/2021
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population. The Laryngoscope	A Tkaczuk, S Trivedi, MD Mody, CE Steuer, DM Shin, AM Klein, NF Saba	03/01/2021
Corrigendum to "FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway" [Canc. Lett. 363 (2015) 166-175]. Cancer letters	A Haque, MA Rahman, JR Fuchs, Z Chen, FR Khuri, DM Shin, ARMR Amin	02/01/2021
Combinatorial approaches targeting the EGFR family and c-Met in SCCHN. Oral oncology	D Wang, Y Lu, S Nannapaneni, CC Griffith, C Steuer, G Qian, X Wang, Z Chen, M Patel, M El-Deiry, DM Shin, X He, ZG Chen, NF Saba	01/01/2021
Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma. PloS one	S Nannapaneni, CC Griffith, KR Magliocca, W Chen, X Lyu, Z Chen, D Wang, X Wang, DM Shin, ZG Chen, NF Saba	01/01/2021
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma. The Laryngoscope	DC Qian, KR Magliocca, AH Aiken, KL Baugnon, DC Brandon, WA Stokes, MW McDonald, MR Patel, HM Baddour, AS Kaka, CE Steuer, NF Saba, DM Shin, JJ Beitler	12/01/2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research	DM Shin, S Nannapaneni, MR Patel, Q Shi, Y Liu, Z Chen, AY Chen, MW El-Deiry, JJ Beitler, CE Steuer, SM Roser, AM Klein, TK Owonikoko, SS Ramalingam, FR Khuri, ZG Chen, NF Saba	11/15/2020
Gut Microbiome Associated with the Psychoneurological Symptom Cluster in Patients with Head and Neck Cancers. Cancers	J Bai, DW Bruner, V Fedirko, JJ Beitler, C Zhou, J Gu, H Zhao, IH Lin, CE Chico, KA Higgins, DM Shin, NF Saba, AH Miller, C Xiao	09/06/2020
Corrigendum: Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth. Angewandte Chemie (International ed. in English)	MA Rahman, P Wang, Z Zhao, D Wang, S Nannapaneni, C Zhang, Z Chen, CC Griffith, SJ Hurwitz, ZG Chen, Y Ke, DM Shin	07/27/2020
Demographic and Socioeconomic Factors Associated With Metastases at Presentation in HPV-Related Squamous Cell Carcinoma of the Head and Neck: An NCDB Analysis. JCO oncology practice	MB Bean, JM Switchenko, CE Steuer, M Patel, K Higgins, M McDonald, GZ Chen, JJ Beitler, DM Shin, T Gillespie, NF Saba	06/01/2020
Association Among Glucocorticoid Receptor Sensitivity, Fatigue, and Inflammation in Patients With Head and Neck Cancer. Psychosomatic medicine	C Xiao, RC Eldridge, JJ Beitler, KA Higgins, CE Chico, JC Felger, EC Wommack, T Knobf, NF Saba, DM Shin, DW Bruner, AH Miller	06/01/2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines	R Bommireddy, LE Munoz, A Kumari, L Huang, Y Fan, L Monterroza, CD Pack, S Ramachandiran, SJC Reddy, J Kim, ZG Chen, NF Saba, DM Shin, P Selvaraj	04/14/2020
Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC). PloS one	NF Saba, AR Dinasarapu, KR Magliocca, B Dwivedi, S Seby, ZS Qin, M Patel, CC Griffith, X Wang, M El-Deiry, CE Steuer, J Kowalski, DM Shin, ME Zwick, ZG Chen	01/01/2020
Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data. The oncologist	MB Bean, Y Liu, R Jiang, CE Steuer, M Patel, MW McDonald, KA Higgins, JJ Beitler, DM Shin, NF Saba	12/01/2019
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation. The Journal of clinical investigation	C Pan, J Chun, D Li, AC Boese, J Li, J Kang, A Umano, Y Jiang, L Song, KR Magliocca, ZG Chen, NF Saba, DM Shin, TK Owonikoko, S Lonial, L Jin, S Kang	10/01/2019
Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma. Head and neck pathology	GB Lesinski, S Nannapaneni, CC Griffith, M Patel, W Chen, Z Chen, R Ahmed, A Wieland, DM Shin, ZG Chen, NF Saba	09/01/2019
Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. The Journal of clinical investigation	C Pan, L Jin, X Wang, Y Li, J Chun, AC Boese, D Li, HB Kang, G Zhang, L Zhou, GZ Chen, NF Saba, DM Shin, KR Magliocca, TK Owonikoko, H Mao, S Lonial, S Kang	05/13/2019
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis. Head & neck	A Mohamed, B Twardy, MA Zordok, K Ashraf, A Alkhoder, K Schrapp, C Steuer, Z Chen, S Pakkala, R Pillai, J Trad Wadsworth, K Higgins, JJ Beitler, SS Ramalingam, TK Owonikoko, FR Khuri, DM Shin, M Behera, NF Saba	05/01/2019
Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer. American journal of clinical oncology	NF Saba, S Force, C Staley, F Fernandez, F Willingham, A Pickens, K Cardona, Z Chen, L Goff, D Cardin, E Lambright, J Nesbitt, A Krasinskas, K Higgins, RD Harvey, T Owonikoko, SS Ramalingam, DM Shin, JJ Beitler, BF El-Rayes, S Salaria, W El-Rifai, J Landry, AB Chakravarthy	04/01/2019
Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx. Cancer	JJ Beitler, JM Switchenko, JJ Dignam, MW McDonald, NF Saba, DM Shin, KR Magliocca, RJ Cassidy, MW El-Deiry, MR Patel, CE Steuer, C Xiao, PA Hudgins, AH Aiken, WJ Curran, QT Le	03/01/2019
Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico	TM Morgan, X Wang, X Qian, JM Switchenko, S Nie, KR Patel, RJ Cassidy, DM Shin, JJ Beitler	03/01/2019
Prognostic implications of peritumoral vasculature in head and neck cancer. Cancer medicine	M Evans, HM Baddour, KR Magliocca, S Müller, S Nannapaneni, AY Chen, S Kim, Z Chen, DM Shin, AY Wang, NF Saba, ZG Chen	01/01/2019
Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma. Nutrition and cancer	LS Rozek, S Virani, EL Bellile, JMG Taylor, MA Sartor, KR Zarins, A Virani, C Cote, FP Worden, MEP Mark, SA McLean, SA Duffy, GH Yoo, NF Saba, DM Shin, O Kucuk, GT Wolf	01/01/2019
Differential regulation of NF-kB and IRF target genes as they relate to fatigue in patients with head and neck cancer. Brain, behavior, and immunity	C Xiao, JJ Beitler, KA Higgins, EC Wommack, NF Saba, DM Shin, DW Bruner, AH Miller, S Cole	11/01/2018
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. Cancer cell	L Jin, J Chun, C Pan, D Li, R Lin, GN Alesi, X Wang, HB Kang, L Song, D Wang, G Zhang, J Fan, TJ Boggon, L Zhou, J Kowalski, CK Qu, CE Steuer, GZ Chen, NF Saba, LH Boise, TK Owonikoko, FR Khuri, KR Magliocca, DM Shin, S Lonial, S Kang	08/13/2018
Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer. Cancer	C Xiao, JJ Beitler, KA Higgins, T Glazer, LK Huynh, S Paul, JC Felger, EC Wommack, NF Saba, DM Shin, DW Bruner, AH Miller	08/01/2018
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma. Oral oncology	R Ferrarotto, WN William, JE Tseng, S Marur, DM Shin, B Murphy, EEW Cohen, CY Thomas, R Willey, J Cosaert, N Harun, J Jack Lee, IW Wistuba, RI Haddad, BS Glisson	07/01/2018
Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung. Cancer cytopathology	KZ Hanley, ZJ Dureau, C Cohen, DM Shin, TK Owonikoko, GL Sica	04/01/2018
A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma. Molecular cancer therapeutics	CE Steuer, CC Griffith, S Nannapaneni, MR Patel, Y Liu, KR Magliocca, MW El-Deiry, C Cohen, TK Owonikoko, DM Shin, ZG Chen, NF Saba	03/01/2018
Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells. Journal of the American Chemical Society	P Wang, MA Rahman, Z Zhao, K Weiss, C Zhang, Z Chen, SJ Hurwitz, ZG Chen, DM Shin, Y Ke	02/21/2018
Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin. Clinical cancer research : an official journal of the American Association for Cancer Research	X Wang, JJ Beitler, W Huang, G Chen, G Qian, K Magliocca, MR Patel, AY Chen, J Zhang, S Nannapaneni, S Kim, Z Chen, X Deng, NF Saba, ZG Chen, JL Arbiser, DM Shin	02/15/2018
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers. Oral oncology	SI Pai, J Jack Lee, TE Carey, WH Westra, S Ferrone, C Moore, MB Mosunjac, DM Shin, RL Ferris	02/01/2018
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer	FO Gleber-Netto, M Zhao, S Trivedi, J Wang, S Jasser, C McDowell, H Kadara, J Zhang, J Wang, WN William, JJ Lee, ML Nguyen, SI Pai, HM Walline, DM Shin, RL Ferris, TE Carey, JN Myers, CR Pickering	01/01/2018
Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth. Angewandte Chemie (International ed. in English)	MA Rahman, P Wang, Z Zhao, D Wang, S Nannapaneni, C Zhang, Z Chen, CC Griffith, SJ Hurwitz, ZG Chen, Y Ke, DM Shin	12/11/2017
Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. Head & neck	H Zhang, S Kim, Z Chen, S Nannapaneni, AY Chen, CE Moore, G Sica, M Mosunjac, MLT Nguyen, G D'Souza, TE Carey, LA Peterson, JB McHugh, M Graham, CM Komarck, GT Wolf, HM Walline, E Bellile, J Riddell, SI Pai, D Sidransky, WH Westra, WN William, JJ Lee, AK El-Naggar, RL Ferris, R Seethala, JR Grandis, ZG Chen, NF Saba, DM Shin	12/01/2017
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base. Cancer	KB Naik, Y Liu, M Goodman, TW Gillespie, A Pickens, SD Force, CE Steuer, TK Owonikoko, SS Ramalingam, K Higgins, JJ Beitler, DM Shin, FF Willingham, B El-Rayes, JC Landry, FG Fernandez, NF Saba	09/15/2017
Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status. Oncotarget	J Zhang, S Nannapaneni, D Wang, F Liu, X Wang, R Jin, X Liu, MA Rahman, X Peng, G Qian, ZG Chen, KK Wong, FR Khuri, W Zhou, DM Shin	08/29/2017
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review. JAMA oncology	CE Steuer, M Behera, V Ernani, KA Higgins, NF Saba, DM Shin, S Pakkala, RN Pillai, TK Owonikoko, WJ Curran, CP Belani, FR Khuri, SS Ramalingam	08/01/2017
Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis. Oncogene	L Jin, J Chun, C Pan, GN Alesi, D Li, KR Magliocca, Y Kang, ZG Chen, DM Shin, FR Khuri, J Fan, S Kang	07/06/2017
Modulation of Bax and mTOR for Cancer Therapeutics. Cancer research	R Li, C Ding, J Zhang, M Xie, D Park, Y Ding, G Chen, G Zhang, M Gilbert-Ross, W Zhou, AI Marcus, SY Sun, ZG Chen, GL Sica, SS Ramalingam, AT Magis, H Fu, FR Khuri, WJ Curran, TK Owonikoko, DM Shin, J Zhou, X Deng	06/01/2017
Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung Cancer. Clinical lung cancer	NF Saba, Y Wang, H Fu, L Koenig, FR Khuri, DM Shin, ZG Chen	05/01/2017
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base. Clinical lung cancer	CE Steuer, M Behera, Y Liu, C Fu, TW Gillespie, NF Saba, DM Shin, RN Pillai, S Pakkala, TK Owonikoko, FR Khuri, SS Ramalingam	05/01/2017
Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice. Proceedings of the National Academy of Sciences of the United States of America	MR Ali, MA Rahman, Y Wu, T Han, X Peng, MA Mackey, D Wang, HJ Shin, ZG Chen, H Xiao, R Wu, Y Tang, DM Shin, MA El-Sayed	04/11/2017
In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance. Molecular cancer therapeutics	AS Anisuzzaman, A Haque, D Wang, MA Rahman, C Zhang, Z Chen, ZG Chen, DM Shin, AR Amin	04/01/2017
Multiple biological functions of Twist1 in various cancers. Oncotarget	Z Zhao, MA Rahman, ZG Chen, DM Shin	03/21/2017
HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models. Clinical cancer research : an official journal of the American Association for Cancer Research	D Wang, G Qian, H Zhang, KR Magliocca, S Nannapaneni, AR Amin, M Rossi, M Patel, M El-Deiry, JT Wadsworth, Z Chen, FR Khuri, DM Shin, NF Saba, ZG Chen	02/01/2017
High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Molecular cancer research : MCR	HM Walline, TE Carey, CM Goudsmit, EL Bellile, G D'Souza, LA Peterson, JB McHugh, SI Pai, JJ Lee, DM Shin, RL Ferris	02/01/2017
Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor. Oncology	M Evans, Y Liu, C Chen, C Steuer, R Cassidy, J Landry, K Higgins, JJ Beitler, F Willingham, TK Owonikoko, SS Ramalingam, DM Shin, NK Jegadeesh, B El-Rayes, F Fernandez, AM Krasinskas, T Gillespie, NF Saba	01/01/2017
RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis. Oncogene	GN Alesi, L Jin, D Li, KR Magliocca, Y Kang, ZG Chen, DM Shin, FR Khuri, S Kang	10/13/2016
Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation. European journal of cancer (Oxford, England : 1990)	G Qian, D Wang, KR Magliocca, Z Hu, S Nannapaneni, S Kim, Z Chen, SY Sun, DM Shin, NF Saba, ZG Chen	09/01/2016
The Challenges of Laryngeal Preservation-Is It the Systemic Agent or the Proper Sequence of Therapy? JAMA otolaryngology-- head & neck surgery	NF Saba, DM Shin	09/01/2016
Biomarker quantification by multiplexed quantum dot technology for predicting lymph node metastasis and prognosis in head and neck cancer. Oncotarget	Z Hu, G Qian, S Müller, J Xu, NF Saba, S Kim, Z Chen, N Jiang, D Wang, H Zhang, K Lane, C Hoyt, DM Shin, ZG Chen	07/12/2016
A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology	G Qian, Z Hu, H Xu, S Müller, D Wang, H Zhang, S Kim, Z Chen, NF Saba, DM Shin, AY Wang, ZG Chen	07/01/2016
Anticancer activity of drug conjugates in head and neck cancer cells. Frontiers in bioscience (Elite edition)	D Majumdar, MA Rahman, ZG Chen, DM Shin	06/01/2016
Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy. Head & neck	S Hanasoge, KR Magliocca, JM Switchenko, NF Saba, JT Wadsworth, MW El-Deiry, DM Shin, F Khuri, JJ Beitler, KA Higgins	06/01/2016
Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	T McKibbin, LL Cheng, S Kim, CE Steuer, TK Owonikoko, FR Khuri, DM Shin, NF Saba	04/01/2016
Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy. Brain, behavior, and immunity	C Xiao, JJ Beitler, KA Higgins, K Conneely, B Dwivedi, J Felger, EC Wommack, DM Shin, NF Saba, LY Ong, J Kowalski, DW Bruner, AH Miller	02/01/2016
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA oncology	WN William, V Papadimitrakopoulou, JJ Lee, L Mao, EE Cohen, HY Lin, AM Gillenwater, JW Martin, MW Lingen, JO Boyle, DM Shin, N Vigneswaran, N Shinn, JV Heymach, II Wistuba, X Tang, ES Kim, P Saintigny, EA Blair, T Meiller, JS Gutkind, J Myers, A El-Naggar, SM Lippman	02/01/2016
Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities. Acta biochimica et biophysica Sinica	J Zhang, D Park, DM Shin, X Deng	01/01/2016
Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers. Cancer prevention research (Philadelphia, Pa.)	AS Anisuzzaman, A Haque, MA Rahman, D Wang, JR Fuchs, S Hurwitz, Y Liu, G Sica, FR Khuri, ZG Chen, DM Shin, AR Amin	01/01/2016
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy. Frontiers in oncology	M Sayan, RJ Cassidy, JM Switchenko, OA Kayode, NF Saba, CE Steuer, DM Shin, JT Wadsworth, M El-Deiry, M Patel, JJ Beitler, KA Higgins	01/01/2016
Antitumor Activity of 2,9-Di-Sec-Butyl-1,10-Phenanthroline. PloS one	D Wang, S Peng, AR Amin, MA Rahman, S Nannapaneni, Y Liu, DM Shin, NF Saba, JF Eichler, ZG Chen	01/01/2016
Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in cancer biology	KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, K Aquilano, J Arbiser, A Arreola, A Arzumanyan, SS Ashraf, AS Azmi, F Benencia, D Bhakta, A Bilsland, A Bishayee, SW Blain, PB Block, CS Boosani, TE Carey, A Carnero, M Carotenuto, SC Casey, M Chakrabarti, R Chaturvedi, GZ Chen, H Chen, S Chen, YC Chen, BK Choi, MR Ciriolo, HM Coley, AR Collins, M Connell, S Crawford, CS Curran, C Dabrosin, G Damia, S Dasgupta, RJ DeBerardinis, WK Decker, P Dhawan, AME Diehl, JT Dong, QP Dou, JE Drew, E Elkord, B El-Rayes, MA Feitelson, DW Felsher, LR Ferguson, C Fimognari, GL Firestone, C Frezza, H Fujii, MM Fuster, D Generali, AG Georgakilas, F Gieseler, M Gilbertson, MF Green, B Grue, G Guha, D Halicka, WG Helferich, P Heneberg, P Hentosh, MD Hirschey, LJ Hofseth, RF Holcombe, K Honoki, HY Hsu, GS Huang, LD Jensen, WG Jiang, LW Jones, PA Karpowicz, WN Keith, SP Kerkar, GN Khan, M Khatami, YH Ko, O Kucuk, RJ Kulathinal, NB Kumar, BS Kwon, A Le, MA Lea, HY Lee, T Lichtor, LT Lin, JW Locasale, BL Lokeshwar, VD Longo, CA Lyssiotis, KL MacKenzie, M Malhotra, M Marino, ML Martinez-Chantar, A Matheu, C Maxwell, E McDonnell, AK Meeker, M Mehrmohamadi, K Mehta, GA Michelotti, RM Mohammad, SI Mohammed, DJ Morre, V Muralidhar, I Muqbil, MP Murphy, GP Nagaraju, R Nahta, E Niccolai, S Nowsheen, C Panis, F Pantano, VR Parslow, G Pawelec, PL Pedersen, B Poore, D Poudyal, S Prakash, M Prince, L Raffaghello, JC Rathmell, WK Rathmell, SK Ray, J Reichrath, S Rezazadeh, D Ribatti, L Ricciardiello, RB Robey, F Rodier, HPV Rupasinghe, GL Russo, EP Ryan, AK Samadi, I Sanchez-Garcia, AJ Sanders, D Santini, M Sarkar, T Sasada, NK Saxena, RE Shackelford, HMC Shantha Kumara, D Sharma, DM Shin, D Sidransky, MD Siegelin, E Signori, N Singh, S Sivanand, D Sliva, C Smythe, C Spagnuolo, DM Stafforini, J Stagg, PR Subbarayan, T Sundin, WH Talib, SK Thompson, PT Tran, H Ungefroren, MG Vander Heiden, V Venkateswaran, DS Vinay, PJ Vlachostergios, Z Wang, KE Wellen, RL Whelan, ES Yang, H Yang, X Yang, P Yaswen, C Yedjou, X Yin, J Zhu, M Zollo	12/01/2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars in cancer biology	ARMR Amin, PA Karpowicz, TE Carey, J Arbiser, R Nahta, ZG Chen, JT Dong, O Kucuk, GN Khan, GS Huang, S Mi, HY Lee, J Reichrath, K Honoki, AG Georgakilas, A Amedei, A Amin, B Helferich, CS Boosani, MR Ciriolo, S Chen, SI Mohammed, AS Azmi, WN Keith, D Bhakta, D Halicka, E Niccolai, H Fujii, K Aquilano, SS Ashraf, S Nowsheen, X Yang, A Bilsland, DM Shin	12/01/2015
HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis	R Marullo, E Werner, H Zhang, GZ Chen, DM Shin, PW Doetsch	11/01/2015
Targeting HER (ERBB) signaling in head and neck cancer: An essential update. Molecular aspects of medicine	J Zhang, NF Saba, GZ Chen, DM Shin	11/01/2015
Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. Cancer	G Qian, N Jiang, D Wang, S Newman, S Kim, Z Chen, G Garcia, G MacBeath, DM Shin, FR Khuri, ZG Chen, NF Saba	10/15/2015
CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	MA Rahman, DM Shin	10/15/2015
FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway. Cancer letters	A Haque, MA Rahman, JR Fuchs, ZG Chen, FR Khuri, DM Shin, AR Amin	07/28/2015
Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2. Apoptosis : an international journal on programmed cell death	A Haque, MA Rahman, ZG Chen, NF Saba, FR Khuri, DM Shin, AR Ruhul Amin	07/01/2015
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. Cancer cell	B Han, D Park, R Li, M Xie, TK Owonikoko, G Zhang, GL Sica, C Ding, J Zhou, AT Magis, ZG Chen, DM Shin, SS Ramalingam, FR Khuri, WJ Curran, X Deng	06/08/2015
Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis. Oral oncology	LJ Joseph, M Goodman, K Higgins, R Pilai, SS Ramalingam, K Magliocca, MR Patel, M El-Deiry, JT Wadsworth, TK Owonikoko, JJ Beitler, FR Khuri, DM Shin, NF Saba	06/01/2015
Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular level. PLoS genetics	D Liu, H Xiong, AE Ellis, NC Northrup, KK Dobbin, DM Shin, S Zhao	06/01/2015
Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis. Lung cancer (Amsterdam, Netherlands)	CE Steuer, M Behera, S Kim, N Patel, Z Chen, R Pillai, NF Saba, DM Shin, TK Owonikoko, FR Khuri, SS Ramalingam	04/01/2015
Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer cell	L Jin, D Li, GN Alesi, J Fan, HB Kang, Z Lu, TJ Boggon, P Jin, H Yi, ER Wright, D Duong, NT Seyfried, R Egnatchik, RJ DeBerardinis, KR Magliocca, C He, ML Arellano, HJ Khoury, DM Shin, FR Khuri, S Kang	02/09/2015
Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor. Cancer	Z Hu, S Müller, G Qian, J Xu, S Kim, Z Chen, N Jiang, D Wang, H Zhang, NF Saba, DM Shin, ZG Chen	01/15/2015
Curcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathways. PloS one	AR Amin, A Haque, MA Rahman, ZG Chen, FR Khuri, DM Shin	01/01/2015
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck. Cancer	NF Saba, SJ Hurwitz, K Magliocca, S Kim, TK Owonikoko, D Harvey, SS Ramalingam, Z Chen, J Rogerio, J Mendel, SA Kono, C Lewis, AY Chen, K Higgins, M El-Deiry, T Wadsworth, JJ Beitler, DM Shin, SY Sun, FR Khuri	12/15/2014
Patients' perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implications. Complementary therapies in clinical practice	KA Hendershot, M Dixon, SA Kono, DM Shin, RD Pentz	11/01/2014
Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303. Clinical cancer research : an official journal of the American Association for Cancer Research	AM Egloff, JW Lee, CJ Langer, H Quon, A Vaezi, JR Grandis, RR Seethala, L Wang, DM Shin, A Argiris, D Yang, R Mehra, JA Ridge, UA Patel, BA Burtness, AA Forastiere	10/01/2014
Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect. The Journal of biological chemistry	J Fan, HB Kang, C Shan, S Elf, R Lin, J Xie, TL Gu, M Aguiar, S Lonning, TW Chung, M Arellano, HJ Khoury, DM Shin, FR Khuri, TJ Boggon, S Kang, J Chen	09/19/2014
Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review. Oral oncology	M Behera, TK Owonikoko, S Kim, Z Chen, K Higgins, SS Ramalingam, DM Shin, FR Khuri, JJ Beitler, NF Saba	09/01/2014
Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth. The Journal of biological chemistry	C Shan, HB Kang, S Elf, J Xie, TL Gu, M Aguiar, S Lonning, T Hitosugi, TW Chung, M Arellano, HJ Khoury, DM Shin, FR Khuri, TJ Boggon, J Fan	08/01/2014
Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS nano	D Wang, B Fei, LV Halig, X Qin, Z Hu, H Xu, YA Wang, Z Chen, S Kim, DM Shin, ZG Chen	07/22/2014
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma. Molecular cancer therapeutics	N Jiang, D Wang, Z Hu, HJ Shin, G Qian, MA Rahman, H Zhang, AR Amin, S Nannapaneni, X Wang, Z Chen, G Garcia, G MacBeath, DM Shin, FR Khuri, J Ma, ZG Chen, NF Saba	07/01/2014
Long-term use of valproic acid in US veterans is associated with a reduced risk of smoking-related cases of head and neck cancer. Cancer	H Kang, TW Gillespie, M Goodman, SA Brodie, M Brandes, M Ribeiro, SS Ramalingam, DM Shin, FR Khuri, JC Brandes	05/01/2014
Epidemiology of head and neck squamous cell cancer among HIV-infected patients. Journal of acquired immune deficiency syndromes (1999)	G Dʼsouza, TE Carey, WN William, ML Nguyen, EC Ko, J Riddell, SI Pai, V Gupta, HM Walline, JJ Lee, GT Wolf, DM Shin, JR Grandis, RL Ferris	04/15/2014
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study. Cancer prevention research (Philadelphia, Pa.)	NF Saba, SJ Hurwitz, SA Kono, CS Yang, Y Zhao, Z Chen, G Sica, S Müller, R Moreno-Williams, M Lewis, W Grist, AY Chen, CE Moore, TK Owonikoko, S Ramalingam, JJ Beitler, S Nannapaneni, HJ Shin, JR Grandis, FR Khuri, ZG Chen, DM Shin	03/01/2014
Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck. Head and neck pathology	NF Saba, KR Magliocca, S Kim, S Muller, Z Chen, TK Owonikoko, NJ Sarlis, C Eggers, V Phelan, WJ Grist, AY Chen, SS Ramalingam, ZG Chen, JJ Beitler, DM Shin, FR Khuri, AI Marcus	03/01/2014
Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer prevention research (Philadelphia, Pa.)	D Majumdar, KH Jung, H Zhang, S Nannapaneni, X Wang, AR Amin, Z Chen, ZG Chen, DM Shin	01/01/2014
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts. Current cancer drug targets	S Zhu, TW Moore, N Morii, RB Howard, D Culver, RF Arrendale, P Reddy, TJ Evers, H Zhang, G Sica, ZG Chen, A Sun, H Fu, FR Khuri, DM Shin, JP Snyder, M Shoji	01/01/2014
Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PloS one	X Wang, JJ Beitler, H Wang, MJ Lee, W Huang, L Koenig, S Nannapaneni, AR Amin, M Bonner, HJ Shin, ZG Chen, JL Arbiser, DM Shin	01/01/2014
The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasis. The Journal of biological chemistry	D Li, L Jin, GN Alesi, YM Kim, J Fan, JH Seo, D Wang, M Tucker, TL Gu, BH Lee, J Taunton, KR Magliocca, ZG Chen, DM Shin, FR Khuri, S Kang	11/08/2013
Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands. Journal of inorganic biochemistry	CD Sanghvi, PM Olsen, C Elix, SB Peng, D Wang, ZG Chen, DM Shin, KI Hardcastle, CE MacBeth, JF Eichler	11/01/2013
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer	B Ansa, M Goodman, K Ward, SA Kono, TK Owonikoko, K Higgins, JJ Beitler, W Grist, T Wadsworth, M El-Deiry, AY Chen, FR Khuri, DM Shin, NF Saba	07/15/2013
RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research	MA Rahman, AR Amin, D Wang, L Koenig, S Nannapaneni, Z Chen, Z Wang, G Sica, X Deng, ZG Chen, DM Shin	07/01/2013
Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma. Head & neck	X Sun, J Li, G Sica, SQ Fan, Y Wang, Z Chen, S Muller, ZG Chen, X Fu, XY Dong, P Guo, DM Shin, JT Dong	07/01/2013
p90 RSK2 mediates antianoikis signals by both transcription-dependent and -independent mechanisms. Molecular and cellular biology	L Jin, D Li, JS Lee, S Elf, GN Alesi, J Fan, HB Kang, D Wang, H Fu, J Taunton, TJ Boggon, M Tucker, TL Gu, ZG Chen, DM Shin, FR Khuri, S Kang	07/01/2013
New perspectives of curcumin in cancer prevention. Cancer prevention research (Philadelphia, Pa.)	W Park, AR Amin, ZG Chen, DM Shin	05/01/2013
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies. British journal of cancer	RD Harvey, TK Owonikoko, CM Lewis, A Akintayo, Z Chen, M Tighiouart, SS Ramalingam, MP Fanucchi, P Nadella, A Rogatko, DM Shin, B El-Rayes, FR Khuri, JS Kauh	03/05/2013
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies. Clinical cancer research : an official journal of the American Association for Cancer Research	DM Shin, H Zhang, NF Saba, AY Chen, S Nannapaneni, AR Amin, S Müller, M Lewis, G Sica, S Kono, JC Brandes, WJ Grist, R Moreno-Williams, JJ Beitler, SM Thomas, Z Chen, HJ Shin, JR Grandis, FR Khuri, ZG Chen	03/01/2013
Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. Head & neck	DM Shin, FR Khuri	03/01/2013
Laryngeal tumor volume as a predictor for thyroid cartilage penetration. Head & neck	SS Kats, S Muller, A Aiken, PA Hudgins, JT Wadsworth, DM Shin, F Khuri, JJ Beitler	03/01/2013
Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer	SS Ramalingam, TK Owonikoko, M Behera, J Subramanian, NF Saba, SA Kono, AA Gal, G Sica, RD Harvey, Z Chen, CM Klass, DM Shin, H Fu, SY Sun, R Govindan, FR Khuri	03/01/2013
N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy. Oncogene	AR Ruhul Amin, VS Thakur, K Gupta, MK Agarwal, DN Wald, DM Shin, ML Agarwal	02/14/2013
Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition. The Journal of biological chemistry	S Zhang, X Wang, S Iqbal, Y Wang, AO Osunkoya, Z Chen, Z Chen, DM Shin, H Yuan, YA Wang, HE Zhau, LW Chung, C Ritenour, O Kucuk, D Wu	01/18/2013
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation. Nature communications	T Hitosugi, L Zhou, J Fan, S Elf, L Zhang, J Xie, Y Wang, TL Gu, M Alečković, G LeRoy, Y Kang, HB Kang, JH Seo, C Shan, P Jin, W Gong, S Lonial, ML Arellano, HJ Khoury, GZ Chen, DM Shin, FR Khuri, TJ Boggon, S Kang, C He, J Chen	01/01/2013
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer. PloS one	R Li, S You, Z Hu, ZG Chen, GL Sica, FR Khuri, WJ Curran, DM Shin, X Deng	01/01/2013
Clinical efficacy of targeted biologic agents as second-line therapy of advanced thyroid cancer. The oncologist	TK Owonikoko, RP Chowdry, Z Chen, S Kim, NF Saba, DM Shin, FR Khuri	01/01/2013
Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer cell	T Hitosugi, L Zhou, S Elf, J Fan, HB Kang, JH Seo, C Shan, Q Dai, L Zhang, J Xie, TL Gu, P Jin, M Alečković, G LeRoy, Y Kang, JA Sudderth, RJ DeBerardinis, CH Luan, GZ Chen, S Muller, DM Shin, TK Owonikoko, S Lonial, ML Arellano, HJ Khoury, FR Khuri, BH Lee, K Ye, TJ Boggon, S Kang, C He, J Chen	11/13/2012
Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer	CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, T Owonikoko, S Ramalingam, DM Shin, FR Khuri, JJ Beitler, NF Saba	09/15/2012
The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research	D Wang, S Müller, AR Amin, D Huang, L Su, Z Hu, MA Rahman, S Nannapaneni, L Koenig, Z Chen, M Tighiouart, DM Shin, ZG Chen	09/01/2012
HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases? Head and neck pathology	S Müller, FR Khuri, SA Kono, JJ Beitler, DM Shin, NF Saba	09/01/2012
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment. International journal of cancer	H Zhang, S Yun, TD Batuwangala, M Steward, SD Holmes, L Pan, M Tighiouart, HJ Shin, L Koenig, W Park, D Rycroft, S Nannapaneni, Y Wang, ZG Chen, DM Shin	08/15/2012
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer. European journal of cancer (Oxford, England : 1990)	J Xu, S Müller, S Nannapaneni, L Pan, Y Wang, X Peng, D Wang, M Tighiouart, Z Chen, NF Saba, JJ Beitler, DM Shin, ZG Chen	07/01/2012
Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts. Integrative biology : quantitative biosciences from nano to macro	S Zhu, TW Moore, X Lin, N Morii, A Mancini, RB Howard, D Culver, RF Arrendale, P Reddy, TJ Evers, H Zhang, G Sica, ZG Chen, A Sun, H Fu, FR Khuri, DM Shin, JP Snyder, M Shoji	06/01/2012
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth. Journal of controlled release : official journal of the Controlled Release Society	MA Rahman, AR Amin, X Wang, JE Zuckerman, CH Choi, B Zhou, D Wang, S Nannapaneni, L Koenig, Z Chen, ZG Chen, Y Yen, ME Davis, DM Shin	05/10/2012
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice. Cancer chemotherapy and pharmacology	SJ Hurwitz, H Zhang, S Yun, TD Batuwangala, M Steward, SD Holmes, D Rycroft, L Pan, M Tighiouart, HJ Shin, L Koenig, Y Wang, ZG Chen, DM Shin	03/01/2012
Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer	S Pakkala, Z Chen, D Rimland, TK Owonikoko, C Gunthel, JR Brandes, NR Saba, DM Shin, WJ Curran, FR Khuri, SS Ramalingam	01/01/2012
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS nano	XH Peng, Y Wang, D Huang, Y Wang, HJ Shin, Z Chen, MB Spewak, H Mao, X Wang, Y Wang, ZG Chen, S Nie, DM Shin	12/27/2011
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene	S Zhang, X Wang, AO Osunkoya, S Iqbal, Y Wang, Z Chen, S Müller, Z Chen, S Josson, IM Coleman, PS Nelson, YA Wang, R Wang, DM Shin, FF Marshall, O Kucuk, LW Chung, HE Zhau, D Wu	12/15/2011
Patterns of extralaryngeal spread of laryngeal cancer: thyroid cartilage penetration occurs in a minority of patients with extralaryngeal spread of laryngeal squamous cell cancers. Cancer	SA Chen, S Muller, AY Chen, PA Hudgins, DM Shin, F Khuri, NF Saba, JJ Beitler	11/15/2011
Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR. Molecular cancer	D Wang, L Su, D Huang, H Zhang, DM Shin, ZG Chen	09/22/2011
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignancies. Cancer	J Kauh, C Chanel-Vos, D Escuin, MP Fanucchi, RD Harvey, N Saba, DM Shin, A Gal, L Pan, M Kutner, SS Ramalingam, L Bender, A Marcus, P Giannakakou, FR Khuri	09/01/2011
A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. ACS nano	X Wang, J Li, Y Wang, L Koenig, A Gjyrezi, P Giannakakou, EH Shin, M Tighiouart, ZG Chen, S Nie, DM Shin	08/23/2011
Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex. Journal of inorganic biochemistry	AN Wein, AT Stockhausen, KI Hardcastle, MR Saadein, SB Peng, D Wang, DM Shin, ZG Chen, JF Eichler	05/01/2011
Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis. Oncology	NF Saba, M Goodman, K Ward, C Flowers, S Ramalingam, T Owonikoko, A Chen, W Grist, T Wadsworth, JJ Beitler, FR Khuri, DM Shin	01/01/2011
c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL. Molecular cancer	L Fu, YD Lin, HA Elrod, P Yue, Y Oh, B Li, H Tao, GZ Chen, DM Shin, FR Khuri, SY Sun	12/20/2010
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53. The Journal of biological chemistry	AR Amin, D Wang, H Zhang, S Peng, HJ Shin, JC Brandes, M Tighiouart, FR Khuri, ZG Chen, DM Shin	11/05/2010
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS nano	X Huang, X Peng, Y Wang, Y Wang, DM Shin, MA El-Sayed, S Nie	10/26/2010
caGrid-Enabled caBIG Silver Level Compatible Head and Neck Cancer Tissue Database System. The open medical informatics journal	H Wang, E Bouzyk, A Kuehn, S Muller, Z Chen, FR Khuri, DM Shin, A Rogatko, M Tighiouart	09/01/2010
Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact. PloS one	HA Elrod, S Fan, S Muller, GZ Chen, L Pan, M Tighiouart, DM Shin, FR Khuri, SY Sun	08/16/2010
Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer. Cancer	SS Ramalingam, RD Harvey, N Saba, TK Owonikoko, J Kauh, DM Shin, SY Sun, S Strychor, M Tighiouart, MJ Egorin, H Fu, FR Khuri	08/15/2010
Chemoprevention of head and neck cancer with green tea polyphenols. Cancer prevention research (Philadelphia, Pa.)	JW Kim, AR Amin, DM Shin	08/01/2010
Cancer prevention with natural compounds. Seminars in oncology	NP Gullett, AR Ruhul Amin, S Bayraktar, JM Pezzuto, DM Shin, FR Khuri, BB Aggarwal, YJ Surh, O Kucuk	06/01/2010
Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	JJ Beitler, S Muller, WJ Grist, A Corey, AM Klein, MM Johns, CL Perkins, LW Davis, U Udayasanker, JC Landry, DM Shin, PA Hudgins	05/10/2010
Targeted delivery of paclitaxel to tumor cells: synthesis and in vitro evaluation. Journal of medicinal chemistry	JM Ndungu, YJ Lu, S Zhu, C Yang, X Wang, G Chen, DM Shin, JP Snyder, M Shoji, A Sun	04/22/2010
p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. The Journal of clinical investigation	S Kang, S Elf, K Lythgoe, T Hitosugi, J Taunton, W Zhou, L Xiong, D Wang, S Muller, S Fan, SY Sun, AI Marcus, TL Gu, RD Polakiewicz, ZG Chen, FR Khuri, DM Shin, J Chen	04/01/2010
Restoration of p53 functions protects cells from concanavalin A-induced apoptosis. Molecular cancer therapeutics	AR Amin, VS Thakur, K Gupta, MW Jackson, H Harada, MK Agarwal, DM Shin, DN Wald, ML Agarwal	02/01/2010
The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer. Current topics in medicinal chemistry	D Majumdar, XH Peng, DM Shin	01/01/2010
Chemopreventive potential of natural compounds in head and neck cancer. Nutrition and cancer	MA Rahman, AR Amin, DM Shin	01/01/2010
Oral cancer prevention advances with a translational trial of green tea. Cancer prevention research (Philadelphia, Pa.)	DM Shin	11/01/2009
Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head & neck	NF Saba, S Edelman, M Tighiouart, J Gaultney, LW Davis, FR Khuri, A Chen, W Grist, DM Shin	11/01/2009
HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS nano	X Wang, J Li, Y Wang, KJ Cho, G Kim, A Gjyrezi, L Koenig, P Giannakakou, HJ Shin, M Tighiouart, S Nie, ZG Chen, DM Shin	10/27/2009
Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer. Head & neck	CM Klass, MS Choe, SJ Hurwitz, M Tighiouart, X Zhang, ZG Chen, DM Shin	10/01/2009
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma. Cancer prevention research (Philadelphia, Pa.)	NF Saba, M Choi, S Muller, HJ Shin, M Tighiouart, VA Papadimitrakopoulou, AK El-Naggar, FR Khuri, ZG Chen, DM Shin	09/01/2009
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells. Nanotechnology	DH Huang, L Su, XH Peng, H Zhang, FR Khuri, DM Shin, ZG Chen	06/03/2009
Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB. Cancer prevention research (Philadelphia, Pa.)	AR Amin, FR Khuri, ZG Chen, DM Shin	06/01/2009
Perspectives for cancer prevention with natural compounds. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	AR Amin, O Kucuk, FR Khuri, DM Shin	06/01/2009
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	FC Holsinger, MS Kies, EM Diaz, AM Gillenwater, JS Lewin, LE Ginsberg, BS Glisson, AS Garden, N Ark, HY Lin, JJ Lee, AK El-Naggar, W Ki Hong, DM Shin, FR Khuri	04/20/2009
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head & neck	NF Saba, X Wang, S Müller, M Tighiouart, K Cho, S Nie, Z Chen, DM Shin	04/01/2009
Advances of cancer therapy by nanotechnology. Cancer research and treatment	X Wang, Y Wang, ZG Chen, DM Shin	03/01/2009
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors. American journal of clinical oncology	WN William, JL Lee, DM Shin, WK Hong, S Liu, JJ Lee, SM Lippman, FR Khuri, ES Kim	02/01/2009
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	VA Papadimitrakopoulou, JJ Lee, WN William, JW Martin, M Thomas, ES Kim, FR Khuri, DM Shin, L Feng, WK Hong, SM Lippman	02/01/2009
Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells. Journal of receptor and signal transduction research	Y Du, Z Li, L Li, ZG Chen, SY Sun, P Chen, DM Shin, FR Khuri, H Fu	01/01/2009
Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. British journal of cancer	H Zhang, L Su, S Müller, M Tighiouart, Z Xu, X Zhang, HJ Shin, J Hunt, SY Sun, DM Shin, ZG Chen	11/18/2008
Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor. International journal of cancer	X Zhang, H Zhang, M Tighiouart, JE Lee, HJ Shin, FR Khuri, CS Yang, Z' Chen, DM Shin	09/01/2008
Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation. Cancer	S Muller, L Su, M Tighiouart, N Saba, H Zhang, DM Shin, Z Chen	07/01/2008
Therapeutic nanoparticles for drug delivery in cancer. Clinical cancer research : an official journal of the American Association for Cancer Research	K Cho, X Wang, S Nie, ZG Chen, DM Shin	03/01/2008
Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base. Head & neck	JD Lawson, K Otto, A Chen, DM Shin, L Davis, PA Johnstone	03/01/2008
Head and neck cancer chemoprevention gets a shot in the arm. Journal of clinical oncology : official journal of the American Society of Clinical Oncology	FR Khuri, DM Shin	01/20/2008
Application of nanotechnology in cancer therapy and imaging. CA: a cancer journal for clinicians	X Wang, L Yang, ZG Chen, DM Shin	01/01/2008
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. International journal of nanomedicine	XH Peng, X Qian, H Mao, AY Wang, ZG Chen, S Nie, DM Shin	01/01/2008
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nature biotechnology	X Qian, XH Peng, DO Ansari, Q Yin-Goen, GZ Chen, DM Shin, L Yang, AN Young, MD Wang, S Nie	01/01/2008
Nanotechnology for targeted cancer therapy. Expert review of anticancer therapy	MD Wang, DM Shin, JW Simons, S Nie	06/01/2007
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Molecular cancer therapeutics	R Sinha, GJ Kim, S Nie, DM Shin	08/01/2006
Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model. Clinical cancer research : an official journal of the American Association for Cancer Research	X Zhang, ZG Chen, MS Choe, Y Lin, SY Sun, HS Wieand, HJ Shin, A Chen, FR Khuri, DM Shin	09/01/2005

Awards

Clinical Oncology Career Development Award from American Cancer Society, 1994
Faculty Scholar Award at the University of Texas M. D. Anderson Cancer Center, 2000
Best Doctors in America, 2003-Present
"Top Doctors" in Atlanta Magazine, 2005-Present
America's Top Doctors in Cancer by Castle Connolly Medical Ltd. 2005-Present
Georgia Cancer Coalition (GCC) Distinguished Scholar Award, 2005
America's Top Oncologist in Cancer by Consumer's Research Council of America, 2007
Cambridge Who's Who Life Time Member, 2007
Francis Kelly Blomeyer Distinguished Chair in Cancer Research, 2008 to present
"MilliPub Club" Award from Emory University School of Medicine, 2011, 2015-2019
Top Doctors featured in U.S. News & World Report, 2012/2013
Korean Broadcasting System (KBS) Overseas Compatriots Award in Science and Technology, 2015
Elected Fellow of American Association of the Advancement of Science (FAAAS) in 2016

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.8	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.7	One star One star One star One star One half star	Provider discussed treatment options
4.7	One star One star One star One star One half star	Provider included you in decisions
4.8	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	05/03/2025	I have told everyone how well the visit went I do recommend Emory to absolutely be a great healthcare facility.
One star One star One star One star One star	05/01/2025	Dr Shin was very thorough, answered all my questions, he was very upbeat, positive and reassuring, provided good patient teaching
One star One star One star One star One star	04/23/2025	Very good
One star One star One star One star Empty star	04/23/2025	All the appointments had was explained as I could understand of my issues
One star One star One star One star One star	04/10/2025	My team was always available to me and always answered me in MyChart
One star One star One star One star One star	04/04/2025	Dr Dong Shin has been most accommodating these last two years. I appreciate him. It is not a reflection on any one when I add, though, that I am rarely comfortable making medical referrals.
One star One star One star One star One star	03/13/2025	Thank you. Excellent care.
One star One star One star One star One star	02/21/2025	Great experience. Concerns and questions were answered.
One star One star One star One star One star	01/19/2025	If improvement could be made, it would be with the very first place where a patient meets registration data entry persons. Some data entry folks are personable, others are more similar to cattle drivers. No patient is there for hospitality, but probably some basic sensitivity training for entry level staff and patience with patients would be greatly appreciated.
One star One star One star One star Empty star	12/05/2024	1st time seeing Dr. Shin. Have to see him on more visits to get a better view of him.
One star One star One star One star One star	11/23/2024	I'm always glad they're there
One star One star One star One star One star	10/16/2024	Very good
One star One star One star One star One star	08/28/2024	My Experience was was Excellent.
One star One star One star One star One star	06/12/2024	It's all good but as a lay person I don't make referrals